Suchergebnisse - "Ladhani, Shamez N"

PubPharm (15)

1

Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection

enthalten in: The Journal of infection | 2023

von Dowell, A. | Tut, G. | Begum, J. | +17

2

Nucleocapsid-specific antibodies as a correlate of protection against SARS-CoV-2 reinfection in children

enthalten in: The Journal of infection | 2023

von Dowell, A. | Waiblinger, D. | Wright, J. | +3

3

Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents : National, Prospective Cohort Study

enthalten in: The Pediatric infectious disease journal | 2023

von Aiano, F. | Ireland, G. | Baawuah, F. | +18

4

National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England : the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children

enthalten in: The Journal of infection | 2023

von Powell, A. | Ireland, G. | Leeson, R. | +34

5

SARS Antibody Testing in Children : Development of Oral Fluid Assays for IgG Measurements

enthalten in: Microbiology spectrum | 2022

von Hoschler, K. | Ijaz, S. | Andrews, N. | +20

6

mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273

enthalten in: Frontiers in immunology | 2022

von Dowell, A. | Powell, A. | Davis, C. | +35

7

SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies

enthalten in: The Journal of clinical investigation | 2022

von Jeffery-Smith, A. | Burton, A. | Lens, S. | +12

8

Secondary attack rates in primary and secondary school bubbles following a confirmed case : Active, prospective national surveillance, November to December 2020, England

enthalten in: PloS one | 2022

von Powell, A. | Ireland, G. | Baawuah, F. | +27

9

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

enthalten in: Nature communications | 2021

von Amirthalingam, G. | Bernal, J. | Andrews, N. | +15

ErratumIn: Nat Commun. 2022 Feb 2;13(1):733. - PMID 35110555

10

Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff : Active prospective surveillance, December 2020 to March 2021, England

enthalten in: The Journal of infection | 2021

von Ladhani, S. | Ireland, G. | Baawuah, F. | +19